IP Library › Granted Patent US 10,076,577
Granted Patent B2
US 10,076,577 · App. 15/043,409 · Granted Sep 18, 2018

Compositions and methods for treating endocrine, gastrointestinal or autoimmune disorders

Inventors: John C. March (Ithaca, NY); Franklin Faping Duan (Syracuse, NY)
Assignee: Cornell University
A61K48/0075A61K35/74A61K35/744A61K35/747A61K48/00A61K48/0025C07K14/4702C07K14/605C12N15/746A61K48/0008A61K2035/115C07K2319/02C07K2319/10C12N2830/002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,076,577
App. No.
15/043,409
Granted
Sep 18, 2018
Kind
B2
Abstract

Recombinant cells and methods are provided that relate to the use of isolated, engineered recombinant cells to directly or indirectly treat diseases or disorders in a mammalian host such as endocrine, gastrointestinal or autoimmune disorders. A recombinant cell is provided that comprises a signal sequence and a promoter, wherein: the signal sequence is capable of regulating signal-dependent expression of a target nucleic acid in a host or is capable of regulating signal-dependent expression of a target nucleic acid in response to an environmental stimulus, the cell is derived from an enteric or a commensal bacterium, and the target nucleic acid encodes a mammalian factor that promotes normal functioning of a physiological process in the host or is effective in preventing onset, establishment, or spread of a non-infectious disease in the host. The recombinant cell is administered to the host to treat the disease or disorder.

Claims (8)

1. An isolated recombinant enteric, commensal bacterium that comprises a promoter linked to coding sequences that encodes a secretion tag and GLP-1(1-37),

wherein the recombinant enteric, commensal bacterium is a recombinant Lactobacillus bacterium wherein the promoter is an SlpA promoter having SEQ ID NO:20 and the secretion tag comprises USP45 secretion tags sequences and LEISS sequences.

2. An isolated recombinant enteric, commensal bacterium that comprises a promoter linked to coding sequences that encodes a secretion tag and GLP-1(1-37),

wherein the recombinant enteric, commensal bacterium is a recombinant Lactobacillus bacterium wherein the promoter is an SlpA promoter and the secretion tag comprises USP45 secretion tags sequences encoded by SEQ ID NO:21 and LEISS sequences encoded by SEQ ID NO:22.

3. An isolated recombinant enteric, commensal bacterium that comprises a promoter linked to coding sequences that encodes a secretion tag and GLP-1(1-37),

wherein the recombinant enteric, commensal bacterium is a recombinant Lactobacillus bacterium wherein the promoter is an SlpA promoter having SEQ ID NO:20, and USP45 secretion tags sequences encoded by SEQ ID NO:21, and LEISS sequences encoded by SEQ ID NO:22, and the coding sequence that encodes GLP-1(1-37) is SEQ ID NO:25.

4. An isolated recombinant enteric, commensal bacterium that comprises a promoter linked to coding sequences that encodes a secretion tag and GLP-1(1-37),

wherein the recombinant enteric, commensal bacterium is a recombinant E. coli bacterium comprising SEQ ID NO:4 or SEQ ID NO:10.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2016
From: MARCH, JOHN C.; DUAN, FRANKLIN FAPING
To: CORNELL UNIVERSITY
Reel/Frame 039423/0031 →
Continuity (4)
Division 13879501
Provisional Application 61393618 · Oct 15, 2010
Provisional Application 61539121 · Sep 26, 2011
Related Publication 20160220701A1 · Aug 4, 2016